Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis-Reference-Cited by-同舟云学术

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis

Published:2023-05-12 Issue:4 Volume:12 Page:1119-1132
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Anderson-Smits Colin^ORCID,Ritchey Mary E.^ORCID,Huang Zhongwen,Chavan Shailesh,Souayah Nizar^ORCID,Ay Hakan,Layton J. Bradley^ORCID

Funder

Takeda Development Center Americas, Inc.

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s40120-023-00478-5.pdf

Reference41 articles.

1. Boukhris S, Magy L, Gallouedec G, et al. Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases. J Peripher Nerv Syst. 2005;10(3):329–37. https://doi.org/10.1111/j.1085-9489.2005.10311.x.

2. Guptill JT, Bromberg MB, Zhu L, et al. Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2014;50(1):47–51. https://doi.org/10.1002/mus.24109.

3. Merkies IS, Kieseier BC. Fatigue, pain, anxiety and depression in Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol. 2016;75(3–4):199–206. https://doi.org/10.1159/000445347.

4. Westblad ME, Forsberg A, Press R. Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy. Disabil Rehabil. 2009;31(9):720–5. https://doi.org/10.1080/09638280802306497.

5. Koike H, Nishi R, Ikeda S, et al. Ultrastructural mechanisms of macrophage-induced demyelination in CIDP. Neurology. 2018;91(23):1051–60.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain Related to Chronic Inflammatory Demyelinating Polyneuropathy: A Proof-of-Concept Study;Journal of Clinical Medicine;2024-05-09

2. Therapeutic progress and future prospects of chronic inflammatory demyelinating polyradiculoneuropathy;Clinical and Experimental Neuroimmunology;2024-04-23